Tweets
In case you missed it:
FDA Approves Avacopan for ANCA-Associated Vasculitis
https://t.co/L7UwhYBaVY
#RheumNow https://t.co/HypjLMLwjU
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 9 months ago
ICYMI:
Triple DMARD Rx - MSH vs MLH (Lef). 136 active #RA pts given OL MTX/SSZ/HCQ vs MTX/HCQ/LEF. Equal efficacy (EULAR-Good) was seen at wk 12 (54% vs 59%) and wk 24 (65% vs 62%) - hence LEF substitution was noninferior. https://t.co/F5CGj0w7Bh https://t.co/OuDMgNIKTA
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 9 months ago
For best practices in managing the Delta wave, the US would have done well to consult Puerto Rico
US 26 cases/100,000 people, 19/100K hospitalized 57% vaccinated
PR 3 cases/100,000 people, 3/100K hospitalized, 68% vaccinated https://t.co/kqlXBlmYpu
Eric Topol @EricTopol ( View Tweet )
4 years 9 months ago
This 15-day-old boy developed this rash, which was diagnosed with neonatal lupus; anti-Ro and anti-La Abs were present, in both, mother and child. The mother never had had symptoms suggesting SLE or any autoimmune disease. The rash healed after 45 days; the boy is doing greatđ https://t.co/fYB0IzE7kY
Emilio Martin Mola @emartinmola ( View Tweet )
4 years 9 months ago
In case you missed itâŚa popular read.
Clinical Associations with Myositis Antibodies
Read the full article on #RheumNow
https://t.co/tzPU1scc8x https://t.co/pmmtmIuz31
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 9 months ago
New podcast titled Quackademia available for download.
https://t.co/Y6Pqko1tYm https://t.co/Hm22p70d5e
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 9 months ago
Stillâs Disease Following COVID-19 Vaccination
https://t.co/23R41Pydve https://t.co/y0loTQuKBH
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 9 months ago
Fluorosis presenting as lower back pain and stiffness of the neck, shoulders, hips, yellowish-brown tooth discoloration, LOM of Cx spine, hips, shoulders. Pelvic Xrays showed osteosclerosis without sacroiliitis. T scores were +12.1 LS spine, alk phos =479 https://t.co/t2lmoudUIM https://t.co/6dWH0Rqhva
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 9 months ago
CXCL13 predicts worse Xray status in early #RA. Study of 158 pts, followed 11-years. Baseline CXCL13 correlated with Xray progression (ÎTSS) at 11âyears. CXCL13 was superior to CRP, DAS28CRP, SJC28, CCP predicting 11-yr Xray damage https://t.co/1WAdZoYQ1P
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 9 months ago
Risk of anterior uveitis w/ secukinumab is equal to etanercept; but both inferior to mAb TNFi (infliximab, adalimumab) ~ 5000 Rx starts, AU risk/100PY = SEC 6.8; ETA 7.5; INFLIX 2.9; ADA 4. SEC has a 2.3 fold greater risk than ADA/INFX https://t.co/DB9G2mz4mN
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 9 months ago
Among 2359 RA & PsA pts (3169 TNFi courses 1778/1391), serious infection (SIE) rates were higher in RA 4.17/100PY vs PsA 2.16/100PY. PsA had 41% lower SIE risk (HR 0.59, p=0.004) - Registry data from the NOR-DMARD study https://t.co/llH07TFHOI
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 9 months ago
Retrospective study hospitalized new-onset systemic JIA (2008-19):52 childrenâs hospitals & 534 sJiAshows 29% rx w/ biologics & 58% steroids. Over time Biologic use increased & MTX decreased. Biologic correlated w/ Hi hospital volume, ICU stay, later years https://t.co/blbOps9zVQ
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 9 months ago
